OphtiMed Rx LTD is a preclinical ophthalmic drug development company led by experts in ophthalmology, molecular biology, biotech, out-licensing, and M&As.
The company is developing a novel molecular therapy for dry Age-related Macular Degeneration (AMD), a leading cause of blindness affecting millions worldwide. Yet, no effective treatments exist to prevent retinal damage and vision loss.
Our drug targets the aging process (cellular senescence) that underlies AMD, offering a transformative solution to halt the disease in its early stages and preserve vision.
Our cutting-edge therapy will prevent the loss of vision and independence and bring enormous benefits to patients.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 4 Barnea, Katzrin,israel
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.ophtimedrx.com/
- HQ
- Katzrin
Ophtimed Rx Questions
Ophtimed Rx's website is https://www.ophtimedrx.com/
Ophtimed Rx's LinkedIn profile is https://www.linkedin.com/company/ophtimedrx
Ophtimed Rx has
4 employees.
View email and phone details for 4
employees at Ophtimed Rx.
Ophtimed Rx's industry is
Biotechnology Research
Ophtimed Rx's top competitors are
Symbiosis,
Aummune,
Simplicoai,
Coda,
Liposphere Ltd.,
Selectika Ai,
Cytoreason,
Yazamiyot - Women Entrepreneurs,
Predicta Med,
Cell-Lipo.
Ophtimed Rx's categories are Biotechnology Research
Ophtimed Rx's founding year is 2021
